首页 /研究 /1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC
SURGICAL

1O Dynamic circulating tumour DNA (ctDNA) response to neoadjuvant (NA) atezolizumab (atezo) and surgery (surg) and association with outcomes in patients (pts) with NSCLC

Mark G. Kris, Jessica M. Grindheim, Jamie E. Chaft, J.M. Lee, Bruce E. Johnson, Valerie W. Rusch, Paul A. Bunn, Harvey I. Pass, E. Schum, Jennifer W. Carlisle, M. Weyant, A. Nicholas, Ann Johnson, D. Shames, Ignacio I. Wistuba, David P. Carbone, Katja Schulze, David J. Kwiatkowski

发表年份
2021
引用次数
35

关键词

MedicineAtezolizumabOncologyInternal medicineNeoadjuvant therapyCancerImmunotherapyPembrolizumabBreast cancer

相关论文

查看 SURGICAL 分类全部论文